Edgemoor Investment Advisors, Inc. Biogen Inc. Transaction History

Edgemoor Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $239,184 - $268,268	-1,100 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$216.71 - $338.96 $43,342 - $67,792	200 Added 22.22%	1,100 $260,000
Q2 2018 Aug 02, 2018	SELL	$257.52 - $306.91 $6,438 - $7,672	-25 Reduced 2.7%	900 $261,000
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $61,528 - $68,916	200 Added 27.59%	925 $313,000
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $203,833 - $239,025	725	725 $227,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Edgemoor Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Edgemoor Investment Advisors, Inc. with notifications on news.